Home

OrbiMed Advisors Israel II, 10% Owner: Damora Therapeutics DMRA Sell · Filed 23/08/17

Trade details

Type
Insider sale
Amount
$401,650.5
Shares · price
535,534 sh · $0.75 a share
Held after
1,510,375 sh
Trade date
23/08/15
Filed
23/08/17
Days to filing
2 days

Sold 26.2% of holdings

Share of holding sold
26.2%

Damora Therapeutics trades, last 26 weeks

What else happened in Damora Therapeutics around then

Filed or reported within 30 days of the trade day · 23/07/16~23/09/14

OrbiMed Advisors Israel II's recent trades